ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,028, issued on July 7, was assigned to UNIVERSITE DE LIMOGES (Limoges, France).
"Therapeutic potential of cellulose-cyclodextrin-curcumin nanocrystals in the treatment of peripheral neuropathies" was invented by Martial Caillaud (Limoges Cedex, France), Alexis Desmouliere (Limoges Cedex, France), Fabrice Billet (Limoges Cedex, France), Franck Sturtz (Limoges Cedex, France), Gautier Marck Arthur Ndong-Ntoutoume (Limoges Cedex, France), Vincent Sol (Limoges Cedex, France) and Robert Granet (Limoges Cedex, France).
According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a complex including: cellulose nanocrystals; at least one Beta-cyclodextrin molecu...